Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
27. April 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 7955
Artikel 1 - 20 / 159092
A plain language review of results from the LAURA study: osimertinib after chemoradiotherapy for patients with EGFR-mutated non-small cell lung cancer that cannot be removed by surgery.
Future Oncol
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüro, Casarini I, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS.
PMID: 42037107 [PubMed - as supplied by publisher]
Using Regression Discontinuity in Time to Strengthen Real-World Evidence: A Case Study in Lung Cancer.
Med Decis Making
Chen NC, Zemplenyi AT, Adamson B, Kaizer AM, O'Bryant CL, McQueen RB, Anderson KE.
PMID: 42037076 [PubMed - as supplied by publisher]
Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs. immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.
Chin Med J (Engl)
Huang Z, Mei S, Liu J, Zhang Q, Li Z, Jiang G, Wang F, Zhang C, Lu C, Zhang M, Chen Z, Deng Y, Xu C, Wu Y, Chang J, Feng W, Zhou Q.
PMID: 42036883 [PubMed - as supplied by publisher]
Impact of the Oncologist's Recommendation on Exercise Levels and Quality of Life in Patients With Lung Cancer: The ORE Randomized Controlled Trial.
Cancer Med
Avancini A, Belluomini L, Giannarelli D, Insolda J, Borsati A, Sposito M, Menis J, Lavagnolo P, Tregnago D, Trestini I, Schena F, Milella M, Pilotto S.
PMID: 42036773 [PubMed - indexed for MEDLINE]
CT radiomics approach to predict response to bronchial arterial chemoembolization in advanced lung cancer by multicenter study.
Sci Rep
Yang D, Tu J, Lin G, Wang Z, Lai L, Kong C, Chen W, Xia S, Lu C, Xu M, Yao H, Yu C, Chen M, Yu R, Ji J.
PMID: 42036487 [PubMed - as supplied by publisher]
Enhanced lung cancer cell inhibition using thymol nano-formulation: Design, physicochemical profiling, cytotoxic assessment, and computational interaction studies.
Biochem Biophys Res Commun
Xue Y, Chen P, Li M, Han B, He M, Sun Z.
PMID: 42035620 [PubMed - as supplied by publisher]
Impact of lung cancer diagnosis on patient lifestyle and physical activity.
Clin Transl Oncol
Marín AJ, González SC, Cruz-Castellanos P, Franco LF, Collado NR, García-Coll V, Castellanos-Montealegre M.
PMID: 42034882 [PubMed - as supplied by publisher]
Biaxially rotational noncoplanar radiotherapy vs. coplanar radiotherapy: A planning study for non-small-cell lung cancer.
Med Dosim
Tomoda R, Aoyama T, Kitagawa T, Hashimoto S, Koide Y, Tachibana H, Kodaira T.
PMID: 42034522 [PubMed - as supplied by publisher]
Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan.
Respir Investig
Okazaki Y, Yoshioka H, Ikoma T, Araki K, Makihara N, Kitagawa M, Nagata Y, Fujii K, Okuno Y, Kamisako K, Nakanishi K, Ikeda Y, Yoshida K, Nakahama K, Takeyasu Y, Katsushima U, Yamanaka Y, Ikeda S, Kurata T.
PMID: 42034368 [PubMed - as supplied by publisher]
Predictive value of delta-radiomic features for the prognosis of patients with stage IA lung adenocarcinoma.
Clin Imaging
Zhong F, Li W, Lu Q, Wu L, Fang Y, Yu P, Zhao S.
PMID: 42034079 [PubMed - as supplied by publisher]
Patterns of Infection and Their Impact on Survival in Lung Cancer Patients: A Retrospective Study From Saudi Arabia.
J Epidemiol Glob Health
Abdalla H, Abaalala R, Alsaadoun N, Robaidi H, Dirar Q, Abdelfattah SI, Alkattan K, Shibl AM.
PMID: 42033628 [PubMed - as supplied by publisher]
CAR immune cell therapy strategies and advances for lung cancer.
Discov Oncol
Zheng S, Chen Y, Li R, Peng S.
PMID: 42033595 [PubMed - as supplied by publisher]
Mechanobiology of non-small cell lung cancer: bridging tumor mechanics and therapeutic strategies.
Mol Biol Rep
Joshi RD, Patil DN, Yadav KS.
PMID: 42033548 [PubMed - indexed for MEDLINE]
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
Thorac Cancer
Iida Y, Kenmotsu H, Mori K, Morita M, Sekikawa M, Yabe M, Doshita K, Miura K, Kodama H, Morikawa N, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Ohde Y, Gon Y, Takahashi T.
PMID: 42033063 [PubMed - indexed for MEDLINE]
Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
Peng Y, Zeng Y, Zhang Y, Fan D, Wang S, Deng C, Ma F, Qiu Z, Chen C, Hu Y, Hu C, Liu W, Wu F.
PMID: 42032980 [PubMed - indexed for MEDLINE]
Empirical Osimertinib as a Second-Line Treatment Is a Viable Option Following First- and Second-Generation TKI Therapy With Unknown EGFR Status in Treated Non-Small Cell Lung Cancer: A Retrospective Study.
Cancer Med
Lin MH, Chu KA, Chen CF, Jiang YC, Hong WC, Hung MY, Hsu CH.
PMID: 42032945 [PubMed - indexed for MEDLINE]
First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis.
Immunotherapy
Zhang Z, Meng K, Wu M, Li A, Yi Y, Shi C, Wan X, Tan C, Jiang Z.
PMID: 42032906 [PubMed - as supplied by publisher]
Uterine angiosarcoma diagnosed solely by endometrial biopsy and the effect of oral progesterone treatment on associated lung metastases.
BMJ Case Rep
Abu Shamleh R, Das N, Lutchman Singh K.
PMID: 42031396 [PubMed - indexed for MEDLINE]
Pseudocellulitis in a patient with non-small cell lung cancer on carboplatin, pemetrexed and pembrolizumab.
BMJ Case Rep
Beadman T, Chan MM.
PMID: 42031384 [PubMed - indexed for MEDLINE]
Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trial.
J Thorac Oncol
Huang J, Chen G, Wang Z, Jin W, Zhao Y, Zhang Y, Zhuang W, Xin Y, Wang Y, Zhou J, Sun L, Jin B, Zhang G, Yao W, Yi T, Du X, Ning F, Chang J, Guo Y, Hu Y, Wang C, Ouyang W, Cai Z, Han B, Meng R, Ding Z, Su H, Li X, Yu X, Chen M, Li G, Zhang Y, Wang J, Ma R, Gong B, Cao C, Wu B, Lei C, Cao J, Zhao Y, Zhou T, Zhao S, Huang Y, Zhang L, Yang Y.
PMID: 42031067 [PubMed - as supplied by publisher]
Artikel 1 - 20 / 159092
Seite 1 von 7955
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung